🇺🇸 FDA
Pipeline program

Mesenchymal Stromal Cells

2022-0751

Phase 2 mab active

Quick answer

Mesenchymal Stromal Cells for Corneal Ulcer is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Corneal Ulcer
Phase
Phase 2
Modality
mab
Status
active

Clinical trials